(19)
(11) EP 2 438 070 A1

(12)

(43) Date of publication:
11.04.2012 Bulletin 2012/15

(21) Application number: 10722324.0

(22) Date of filing: 04.06.2010
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
A61P 25/00(2006.01)
 A61K 31/519(2006.01)
(86) International application number:
PCT/EP2010/003385
(87) International publication number:
WO 2010/139483 (09.12.2010 Gazette 2010/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
BA ME RS

(30) Priority: 04.06.2009 EP 09007403
04.06.2009 US 217773 P

(71) Applicant: Merz Pharma GmbH & Co. KGaA
60318 Frankfurt Main (DE)

(72) Inventors:
  • HENRICH, Markus
    35516 Münzenberg (DE)
  • BAUER, Angela
    55122 Mainz (DE)
  • KRÜGER, Björn
    60437 Frankfurt am Main (DE)
  • KAUSS, Valerjans
    LV-1082 Riga (LV)
  • MÜLLER, Sibylle
    55263 Wackernheim (DE)
  • KUBAS, Holger
    61352 Bad Homburg (DE)
  • ROZHKOVS, Jevgenijs
    LV-2164 Riga (LV)
  • PISKUNOVA, Irene
    LV-1012 Riga (LV)

(74) Representative: Goddard, Christopher Robert 
Dehns St Bride's House 10 Salisbury Square
London EC4Y 8JD
London EC4Y 8JD (GB)

   


(54) GLYCINE B ANTAGONISTS